Runben Biotechnology Co (603193.SS) Stock Price
Runben Biotechnology Co Price
Over the last 6 years Runben Biotechnology Co grew revenue by 33.0% annually, reaching 1.54 B CNY. Earnings per share have grown at 43.7% per year over the last 6 years. For Runben Biotechnology Co, the net margin of 20.4% is broadly stable versus 20.7% a few years ago. At today's price the dividend yield works out to roughly 2.21%. The payout ratio is around 54% of earnings. The consensus 12-month price target for Runben Biotechnology Co is 37.13 CNY, about 91.1% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Runben Biotechnology Co stock price
Runben Biotechnology Co business model & stock analysis
Frequently asked questions about Runben Biotechnology Co
Analysts currently set an average price target of 39.60 CNY for the Runben Biotechnology Co stock (median: 37.13 CNY), implying +103.8 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Runben Biotechnology Co stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Runben Biotechnology Co to generate revenue of 1.86 B CNY and earnings per share of 0.96 CNY.
Converted at the current exchange rate, the Runben Biotechnology Co share trades at 2.58 EUR (19.43 CNY).
The expected revenue of Runben Biotechnology Co is 1.86 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Runben Biotechnology Co is 376.67 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Runben Biotechnology Co is currently 20.32. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Runben Biotechnology Co stock.
The price-to-sales ratio (P/S) of Runben Biotechnology Co is currently 4.13. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Runben Biotechnology Co stock.
The Eulerpool Quality Score for Runben Biotechnology Co is 5/10.
The ISIN of Runben Biotechnology Co is CNE100006DK5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Runben Biotechnology Co is 603193.SS. The ticker symbol is used to trade Runben Biotechnology Co shares on the stock exchange.
Runben Biotechnology Co stock
Runben Biotechnology Co Peer Group
All fundamentals and in-depth analysis of Runben Biotechnology Co
Our stock analysis for Runben Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Runben Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.